ScholarIQanswers from OpenAlex
Osaka International Cancer Institute
InstitutionResearch output, impact & collaborations
Osaka International Cancer Institute is a institution indexed in ScholarIQ from OpenAlex.
What is known about Osaka International Cancer Institute?
ScholarIQrecord summary
Osaka International Cancer Institute is a research organisation in Osaka, JP. OpenAlex records 1,202 works and 23,198 citations for it. 372 researchers list it as their most recent affiliation.
How many works does Osaka International Cancer Institute have?
ScholarIQindexed works
Osaka International Cancer Institute has 1,202 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Osaka International Cancer Institute have?
ScholarIQcitation count
Osaka International Cancer Institute has 23,198 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Osaka International Cancer Institute?
ScholarIQresearcher count
Osaka International Cancer Institute has 372 researchers in the ScholarIQ index.
What is the average h-index at Osaka International Cancer Institute?
ScholarIQavg h-index
Osaka International Cancer Institute has an average h-index of 73 in OpenAlex.
What is the ROR of Osaka International Cancer Institute?
ScholarIQror
The ROR for Osaka International Cancer Institute is on the source record.
What is the OpenAlex record for Osaka International Cancer Institute?
ScholarIQopenalex
The OpenAlex for Osaka International Cancer Institute is on the source record.
Who are the most-cited researchers behind Osaka International Cancer Institute?
ScholarIQtop researchers by citations
What are the most-cited papers on Osaka International Cancer Institute?
ScholarIQmost cited works
Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death
Takashi Nakagawa, Shigeomi Shimizu, Tetsuya Watanabe, Osamu Yamaguchi, Kinya Otsu, Hirotaka Yamagata, Hidenori Inohara, Takeshi Kubo, Yoshihide Tsujimoto
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
Shinichi Yachida, Sayaka Mizutani, Hirotsugu Shiroma, Satoshi Shiba, Takeshi Nakajima, Taku Sakamoto, Hikaru Watanabe, Keigo Masuda, Yuichiro Nishimoto, Masaru Kubo, Fumie Hosoda, Hirofumi Rokutan, Minori Matsumoto, Hiroyuki Takamaru, Masayoshi Yamada, Takahisa Matsuda, Motoki Iwasaki, Taiki Yamaji, Tatsuo Yachida, Tomoyoshi Soga, Ken Kurokawa, Atsushi Toyoda, Yoshitoshi Ogura, Tetsuya Hayashi, Masanori Hatakeyama, Hitoshi Nakagama, Yutaka Saito, Shinji Fukuda, Tatsuhiro Shibata, Takuji Yamada
A prospective, multicenter study of 1111 colorectal endoscopic submucosal dissections (with video)
Yutaka Saito, Toshio Uraoka, Yuichiro Yamaguchi, Kinichi Hotta, Naoto Sakamoto, Hiroaki Ikematsu, Masakatsu Fukuzawa, Nozomu Kobayashi, Junichirou Nasu, Tomoki Michida, Shigeaki Yoshida, Hisatomo Ikehara, Yosuke Otake, Takeshi Nakajima, Takahisa Matsuda, Daizo Saito
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
Masanori Asakura, Masafumi Kitakaze, Seiji Takashima, Yulin Liao, Fuminobu Ishikura, Tsuyoshi Yoshinaka, Hiroshi Ohmoto, Koichi Node, Kohichiro Yoshino, Hiroshi Ishiguro, Hiroshi Asanuma, Shoji Sanada, Yasushi Matsumura, Hiroshi Takeda, Shintaro Beppu, Michihiko Tada, Masatsugu Hori, Shigeki Higashiyama
Narrow‐band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team
Yasushi Sano, Shinji Tanaka, Shin‐ei Kudo, Shôichi Saito, Takahisa Matsuda, Yoshiki Wada, Takahiro Fujii, Hiroaki Ikematsu, Toshio Uraoka, Nozomu Kobayashi, Hisashi Nakamura, Kinichi Hotta, Takahiro Horimatsu, Naoto Sakamoto, Kuang‐I Fu, Osamu Tsuruta, Hiroshi Kawano, Hiroshi Kashida, Yoji Takeuchi, Hirohisa Machida, Toshihiro Kusaka, Naohisa Yoshida, Ichiro Hirata, Takeshi Terai, Hiro‐o Yamano, Kazuhiro Kaneko, Takeshi Nakajima, Taku Sakamoto, Yuichiro Yamaguchi, Naoto Tamai, Naoko Nakano, Nana Hayashi, Shiro Oka, Mineo Iwatate, Hideki Ishikawa, Yoshitaka Murakami, Shigeaki Yoshida, Yutaka Saito
How much of the research on Osaka International Cancer Institute is open access?
ScholarIQopen access share
25%OPEN ACCESS